Kamada Ltd(KMDA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 9 at 4:00 PM ET (Korea 11/10 06:00)
Full metrics table
| Index | - | P/E | 20.17 | EPS (ttm) | 0.38 | Insider Own | 45.13% | Shs Outstand | 57.7M | Perf Week | 4.62% |
| Market Cap | 0.44B | Forward P/E | 13.28 | EPS next Y | 22.11% | Insider Trans | -0.76% | Shs Float | 31.7M | Perf Month | -4.7% |
| Enterprise Value | 0.39B | PEG | 0.61 | EPS next Q | 0.11 | Inst Own | 16.45% | Short Float | 0.62% | Perf Quarter | 8.6% |
| Income | 0.02B | P/S | 2.32 | EPS this Y | 30.26% | Inst Trans | -3.37% | Short Ratio | 1.46 | Perf Half Y | -8.88% |
| Sales | 0.19B | P/B | 1.65 | EPS next 5Y | 21.66% | ROA | 5.92% | Short Interest | 0.20M | Perf YTD | 9.07% |
| Book/sh | 4.67 | P/C | 6.33 | EPS past 3/5Y | - -2.03% | ROE | 8.4% | 52W High | -17.65% ($9.35) | Perf Year | 15.62% |
| Cash/sh | 1.22 | P/FCF | 16.08 | Sales past 3/5Y | 11.74% 6.25% | ROIC | 7.97% | 52W Low | 17.56% ($6.55) | Perf 3Y | 65.59% |
| Dividend Est. | $0.42 (5.45%) | EV/EBITDA | 8.95 | EPS Y/Y TTM | 16.67% | Gross Margin | 40.82% | Volatility(W/M) | 4.24% 2.98% | Perf 5Y | 33.91% |
| Dividend TTM | 0.42 | EV/Sales | 2.01 | Sales Y/Y TTM | 13.17% | Oper. Margin | 14.5% | ATR (14) | 0.32 | Perf 10Y | 41.28% |
| Dividend Ex-Date | 2026/8/27 | Quick Ratio | 2.29 | EPS Q/Q | 25.1% | Profit Margin | 11.6% | RSI (14) | 49.47 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.06 | Sales Q/Q | 22.72% | SMA20 | 0.59% ($7.65) | Beta | 0.94 | Target Price | $13.75 |
| Payout | 64.45% | Debt/Eq | 0.04 | Earnings | 2026/11/9 | SMA50 | -4.55% ($8.07) | Rel Volume | 1.27 | Prev Close | $7.23 |
| Employees | 462 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 22.43% -0.9% | SMA200 | -3.77% ($8) | Avg Volume(3M) | 0.14M | Price | $7.7 |
| IPO | 2013/5/31 | Option/Short | Yes/Yes | Trades | 1575 | Volume | 171,860 | Change | 6.5% |
A global biopharmaceutical company that develops and manufactures plasma-derived specialty immunoglobulin and protein therapies. It maintains a marketed product portfolio targeting rare and serious diseases, and operates numerous plasma collection centers across the United States, establishing a vertically integrated business structure that spans from raw plasma sourcing to finished pharmaceuticals.
Over the past 1 year, roughly in the middle
18% below its 1-year high.
Traded more than usual. That is 127% of its average volume.
KMDA makes money exceptionally well
Of every $100 in sales, $14.50 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +30.3% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,017. Peers typically go for $2,297.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +33.9%. The S&P 500 did +61% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 5.45% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 16.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #41 of 83 in the industry
Based on market cap of $444M.
FAQ
What kind of company is KMDA?
KMDA belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of KMDA?
The market cap of KMDA is approximately $444M, ranking 3,245 within its sector.
Does KMDA pay dividends?
KMDA has a dividend yield of approximately 5.45%, with an annual dividend of $0.42.
What is the P/E ratio of KMDA?
KMDA has a P/E ratio of approximately 20.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for KMDA?
KMDA has recorded a 52-week high of $9.35 and a low of $6.55.
